The Use of Risk Assessment Tools and Prognostic Scores in Managing Patients with Pulmonary Arterial Hypertension

[1]  R. Benza,et al.  Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies. , 2019, Chest.

[2]  S. Söderberg,et al.  A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension , 2018, European heart journal.

[3]  S. Blankenberg,et al.  Right Ventricular Index for Risk Stratification of Patients with Pulmonary Arterial Hypertension , 2018, Respiration.

[4]  R. Benza,et al.  Baseline and Serial Brain Natriuretic Peptide Level Predicts 5‐Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry , 2018, Chest.

[5]  R. Benza,et al.  Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysis. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  Marek J Druzdzel,et al.  Application of Bayesian Model to Predict Outcomes in Pulmonary Arterial Hypertension , 2018 .

[7]  R. Benza,et al.  Risk Assessment in Pulmonary Arterial Hypertension Patients: The Long and Short of it , 2018 .

[8]  M. Humbert,et al.  Risk assessment in pulmonary arterial hypertension , 2018, European Respiratory Journal.

[9]  A. Torbicki,et al.  Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality. , 2018, Journal of the American College of Cardiology.

[10]  M. Humbert,et al.  The Low‐Risk Profile in Pulmonary Arterial Hypertension. Time for a Paradigm Shift to Goal‐oriented Clinical Trial Endpoints? , 2017, American journal of respiratory and critical care medicine.

[11]  M. Humbert,et al.  Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension , 2017, Circulation.

[12]  R. Benza,et al.  Bosentan-based, treat-to-target therapy in patients with pulmonary arterial hypertension: results from the COMPASS-3 study , 2017, Pulmonary circulation.

[13]  J. Paulus,et al.  Racial and ethnic differences in pulmonary arterial hypertension , 2017, Pulmonary circulation.

[14]  S. Rosenkranz,et al.  Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model , 2017, European Respiratory Journal.

[15]  R. Benza,et al.  Assessing risk in pulmonary arterial hypertension: what we know, what we don't , 2017, European Respiratory Journal.

[16]  M. Humbert,et al.  Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension , 2017, European Respiratory Journal.

[17]  R. Ung,et al.  High‐risk echocardiographic features predict mortality in pulmonary arterial hypertension , 2017, American heart journal.

[18]  K. Dimopoulos,et al.  Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[19]  R. Benza,et al.  Updated Risk Score Calculator for Pulmonary Arterial Hypertension Patients , 2017 .

[20]  Justin D. Roberts,et al.  Follow-up tricuspid annular plane systolic excursion predicts survival in pulmonary arterial hypertension , 2017, Pulmonary circulation.

[21]  A. Torbicki,et al.  SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension , 2017, European heart journal.

[22]  M. Kanwar,et al.  Update in treatment options in pulmonary hypertension. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[23]  Tim Leiner,et al.  Cardiac magnetic resonance findings predicting mortality in patients with pulmonary arterial hypertension: a systematic review and meta-analysis , 2016, European Radiology.

[24]  Stephen Kaptoge,et al.  BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis , 2016, The Lancet. Respiratory medicine.

[25]  R. Benza,et al.  Five-Year outcomes of patients enrolled in the REVEAL Registry. , 2015, Chest.

[26]  Simon Gibbs,et al.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension , 2015, European Respiratory Journal.

[27]  M. Humbert,et al.  Validation of two predictive models for survival in pulmonary arterial hypertension , 2015, European Respiratory Journal.

[28]  R. Benza,et al.  Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[29]  R. Benza,et al.  Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: a Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[30]  R. Phipps,et al.  Thrombosis, platelets, microparticles and PAH: more than a clot. , 2014, Drug discovery today.

[31]  M. Mcgoon,et al.  Characterization of First-Time Hospitalizations in Patients With Newly Diagnosed Pulmonary Arterial Hypertension in the REVEAL Registry , 2014, Chest.

[32]  D. Webb,et al.  Endothelin antagonism and uric acid levels in pulmonary arterial hypertension: clinical associations. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[33]  Mary G. George,et al.  Pulmonary Hypertension Surveillance , 2014, Chest.

[34]  J. Marcus,et al.  Changes in Right Ventricular Function Measured by Cardiac Magnetic Resonance Imaging in Patients Receiving Pulmonary Arterial Hypertension–Targeted Therapy: The EURO-MR Study , 2014, Circulation. Cardiovascular imaging.

[35]  A. Peacock,et al.  Cardiac magnetic resonance imaging in pulmonary arterial hypertension , 2013, European Respiratory Review.

[36]  L. Sinak,et al.  Pericardial effusions in pulmonary arterial hypertension: characteristics, prognosis, and role of drainage. , 2013, Chest.

[37]  R. Benza,et al.  Evaluation of the predictive value of a clinical worsening definition using 2-year outcomes in patients with pulmonary arterial hypertension: a REVEAL Registry analysis. , 2013, Chest.

[38]  Mark J Schuuring,et al.  High-sensitivity troponin T is associated with poor outcome in adults with pulmonary arterial hypertension due to congenital heart disease. , 2013, Congenital heart disease.

[39]  M. Arzt,et al.  Impact of right ventricular reserve on exercise capacity and survival in patients with pulmonary hypertension , 2013, European journal of heart failure.

[40]  J. Lordan,et al.  Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. , 2012, American journal of respiratory and critical care medicine.

[41]  Jeroen J. Bax,et al.  Prognostic Value of Right Ventricular Longitudinal Peak Systolic Strain in Patients With Pulmonary Hypertension , 2012, Circulation. Cardiovascular imaging.

[42]  W. Seeger,et al.  HbA1c in pulmonary arterial hypertension: a marker of prognostic relevance? , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[43]  R. Benza,et al.  An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. , 2012, Chest.

[44]  H. Farber.  Validation of the 6-minute walk in patients with pulmonary arterial hypertension: trying to fit a square PEG into a round hole? , 2012, Circulation.

[45]  P. Hassoun,et al.  Pulmonary arterial hypertension in connective tissue diseases. , 2012, Heart failure clinics.

[46]  A. Peacock,et al.  Predicting survival in pulmonary arterial hypertension in the UK , 2012, European Respiratory Journal.

[47]  J. Barberà,et al.  Survival in pulmonary hypertension in Spain: insights from the Spanish registry , 2012, European Respiratory Journal.

[48]  R. Benza,et al.  The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension. , 2012, Chest.

[49]  Nico Westerhof,et al.  Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. , 2011, Journal of the American College of Cardiology.

[50]  T. Welte,et al.  The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension , 2011, European Respiratory Journal.

[51]  R. Benza,et al.  Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[52]  S. Hazen,et al.  Sensitive cardiac troponin I predicts poor outcomes in pulmonary arterial hypertension , 2011, European Respiratory Journal.

[53]  A. Marelli,et al.  Diagnosis of pulmonary hypertension in the congenital heart disease adult population impact on outcomes. , 2011, Journal of the American College of Cardiology.

[54]  M. Mcgoon,et al.  Integration of clinical and hemodynamic parameters in the prediction of long-term survival in patients with pulmonary arterial hypertension. , 2011, Chest.

[55]  Christopher S Coffey,et al.  Predicting Survival in Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) , 2010, Circulation.

[56]  M. Humbert,et al.  Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension , 2010, European Respiratory Journal.

[57]  M. Humbert,et al.  Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era , 2010, Circulation.

[58]  S. Ghio,et al.  Prognostic relevance of the echocardiographic assessment of right ventricular function in patients with idiopathic pulmonary arterial hypertension. , 2010, International journal of cardiology.

[59]  J. E. Hansen,et al.  Usefulness of right-to-left shunting and poor exercise gas exchange for predicting prognosis in patients with pulmonary arterial hypertension. , 2010, The American journal of cardiology.

[60]  Sanjiv J. Shah,et al.  Carbon monoxide diffusing capacity and mortality in pulmonary arterial hypertension. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[61]  T. Nawrot,et al.  C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. , 2009, Journal of the American College of Cardiology.

[62]  Himanshu Gupta,et al.  Role of cardiac magnetic resonance imaging in the management of patients with pulmonary arterial hypertension. , 2008, Journal of the American College of Cardiology.

[63]  G. Raskob,et al.  Design of the REVEAL registry for US patients with pulmonary arterial hypertension. , 2008, Mayo Clinic proceedings.

[64]  P. Hassoun,et al.  Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension. , 2008, American journal of respiratory and critical care medicine.

[65]  M. Humbert,et al.  Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation. , 2008, American journal of respiratory and critical care medicine.

[66]  C. Wiener,et al.  Poor Outcomes Associated with Drainage of Pericardial Effusions in Patients with Pulmonary Arterial Hypertension , 2008, Southern medical journal.

[67]  B. Hartmann,et al.  N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension. , 2007, Chest.

[68]  T. Abraham,et al.  Tricuspid annular displacement predicts survival in pulmonary hypertension. , 2006, American journal of respiratory and critical care medicine.

[69]  J. Krishnan,et al.  Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. , 2006, Arthritis and rheumatism.

[70]  P. Zanen,et al.  Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension. , 2006, Chest.

[71]  H. Su,et al.  Home exposures, parental atopy, and occurrence of asthma symptoms in adulthood in southern Taiwan. , 2006, Chest.

[72]  R. Oudiz.  The role of exercise testing in the management of pulmonary arterial hypertension. , 2005, Seminars in respiratory and critical care medicine.

[73]  R. Barst,et al.  New predictors of outcome in idiopathic pulmonary arterial hypertension. , 2005, The American journal of cardiology.

[74]  R. Favaloro,et al.  Right atrial size and tricuspid regurgitation severity predict mortality or transplantation in primary pulmonary hypertension. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[75]  Gilles Garcia,et al.  Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. , 2002, Journal of the American College of Cardiology.

[76]  J. Sandoval,et al.  Survival in primary pulmonary hypertension. Validation of a prognostic equation. , 1994, Circulation.

[77]  S. Shinohara,et al.  Echocardiographic evaluation of pulmonary arterial hypertension in patients with progressive systemic sclerosis and related syndromes. , 1992, Japanese circulation journal.

[78]  E H Bergofsky,et al.  Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .

[79]  D. O’Regan,et al.  Right ventricular remodelling in pulmonary arterial hypertension with three-dimensional echocardiography: comparison with cardiac magnetic resonance imaging. , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.